{
  "data": {
    "indicator": {
      "slug": "pharmaceuticals-division-sales",
      "name": "Pharmaceuticals division sales",
      "definition": "Revenue generated by the pharmaceuticals division over the specified period.",
      "unit": "CHF",
      "scale": "billion",
      "default_unit": "CHF",
      "default_scale": "billion"
    },
    "scale": "billion",
    "unit": "CHF",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2026-01-01",
        "period_label": "Q1 2026",
        "value": 23.6,
        "scale": "billion",
        "unit": "CHF",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGDS",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGDS",
        "source_org": "Roche",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "document_title": "[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant a...",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-07-23",
          "locator": "Group results",
          "published_date": "2026-07-23"
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}